This small-cap Healthcare stock engaged in operating multi-specialty hospitals, offering healthcare services, outpatient diagnostics, emergency care, and specialized treatments across the National ...

Baird analyst David Koning initiated coverage on the stock with an Outperform rating and a price target of $70 on Oct. 3, 2024. This analyst has an accuracy rate of 76%. Considering buying CNXC stock?

Wedbush hiked its price target on Microsoft to $600 on AI optimism. Brad Pitt opens up about embarrassing career moment that ...